arcadia

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2573.4512.3 (+0.48 %)
PREV CLOSE ( ) 2561.15
OPEN PRICE ( ) 2579.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 31267
TODAY'S LOW / HIGH ( )2538.60 2589.00
52 WK LOW / HIGH ( )1888 2687.45
NSE2573.606.75 (+0.26 %)
PREV CLOSE( ) 2566.85
OPEN PRICE ( ) 2566.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2573.60 (17)
VOLUME 600003
TODAY'S LOW / HIGH( ) 2537.50 2590.00
52 WK LOW / HIGH ( )1887 2670.8
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
16Oct Victory Paper, Orient Green Power and
Victory Paper and Boards India has received approval from its board to..
15Oct Dr. Reddy’s Lab sells Jeedimetla API m
Dr. Reddy’s Laboratories has entered into a definitive agreement for the..
15Oct Dr. Reddy’s Lab surges on the bourses
Dr. Reddys Laboratories is currently trading at Rs. 2504.00, up by 53.65..
15Oct Dr. Reddy's Lab gets approval for Aspi
Dr. Reddy's Laboratories has received an approval for Aspirin and Extend..
10Oct Dr. Reddy’s Lab launches Colesevelam H
Dr. Reddy’s Laboratories has launched Colesevelam HCI Tablets, USP, a th..
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit32895669
Gross Profit 4011 6970
Operating Profit 609715339
Net Sales 2617693593
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Piramal Enterprises (BSE)
 2329.00 (3.45%)
M.Cap ( in Cr)42227.38
TTK Healthcare (BSE)
 961.25 (7.33%)
M.Cap ( in Cr)1358.28
Merck (BSE)
 3058.30 (1.19%)
M.Cap ( in Cr)5076.59
Jenburkt Pharma (BSE)
 672.25 (4.85%)
M.Cap ( in Cr)308.52
Natco Pharma (BSE)
 740.55 (3.28%)
M.Cap ( in Cr)13673.10
Shareholding Pattern
PROMOTERS 26.79%
NON-INSTITUTION 14.6%
MUTUAL FUNDS/UTI 11.32%
FI/BANKS/INSURANCE 5.77%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM